Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03406013
Other study ID # STUDY00016703
Secondary ID NCI-2017-01048ST
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2017
Est. completion date March 31, 2020

Study information

Verified date July 2020
Source OHSU Knight Cancer Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot clinical trial studies how well the True NTH Community of Wellness internet-based exercise and diet support works in improving diet and exercise habits in prostate cancer survivors. Internet-based exercise and diet support may help better control treatment-related side effects and symptoms, better overall quality of life, and lower risk factors associated with cancer progression.


Description:

PRIMARY OBJECTIVES:

I. To determine the feasibility and acceptability of the Community of Wellness web portal among prostate cancer survivors by conducting a randomized controlled study comparing four levels of web-based content and interaction with participants.

SECONDARY OBJECTIVES:

I. To compare efficacy of four levels of web-based content in the Community of Wellness web portal in a pilot randomized controlled trial on exercise and dietary habits, self-efficacy for behavior change, motivation for exercise, and changes in treatment-related side effects.

OUTLINE: Patients are assigned to 1 of 4 groups.

GROUP I: Patients receive "Written Information" which includes access to the TrueNTH open access portal that provides basic written information about exercise and diet.

GROUP II: Patients receive access to "Written Information + Prescription", including written information plus additional an exercise prescription and tailored diet recommendations.

GROUP III: Patients receive access to "Written Information + Prescription + Technology", including written information, exercise prescription + diet recommendation and additional technology components. Patients complete diet and exercise behavior logs and receive educational and motivational text messages about healthy diet and exercise habits.

GROUP IV: Patients receive access to "Written Information + Prescription + Technology + Coaching" and receive written information, exercise prescription + diet recommendation, technology support and a 30-minute (each) diet and exercise consultation plus the ability to receive ongoing advice from coaches via the web portal.

After completion of intervention, patients are followed up at 3 months.


Recruitment information / eligibility

Status Completed
Enrollment 206
Est. completion date March 31, 2020
Est. primary completion date July 31, 2019
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Self-reported prostate cancer diagnosis

- Able to read English on a computer screen

- Able to access a computer, tablet or smartphone at home or public location

- Access to a device capable of receiving plain text messages

- A personal email address

Exclusion Criteria:

- Men who have contraindications to exercise based the American College of Sports Medicine 2016 Exercise pre-participation screening criteria and who do not receive a physician clearance to participate in the moderate intensity physical activity with one or more of the following self-reported conditions:

- heart attack

- heart surgery, cardiac catheterization, or coronary angioplasty

- pacemaker/implantable cardiac defibrillator/rhythm disturbance

- heart valve disease

- heart failure

- heart transplantation

- congenital heart disease

- diabetes

- kidney (renal) disease

- chest discomfort with exertion

- unreasonable breathlessness

- dizziness, fainting or blackouts

- ankle swelling

- unpleasant awareness of forceful, rapid or irregular heart rate

- burning or cramping sensations in your lower legs when walking short distance

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Written Information
Receive written information on diet and exercise relevant to older men with prostate cancer
Prescription
Participants receive tailored exercise prescription and tailored diet recommendations
Technology
Participants receive motivational text messages and can electronically log and track their exercise and diet habits
Coaching
Participants receive access to an exercise and diet coach to provide advice by phone and/or email

Locations

Country Name City State
United States Oregon Health & Science University Portland Oregon
United States UCSF Medical Center-Mount Zion San Francisco California

Sponsors (2)

Lead Sponsor Collaborator
OHSU Knight Cancer Institute Movember Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accrual success Measured as ability to recruit target sample size within one year Up to 3 months
Primary Retention Measured as the % of men who complete post-intervention and follow-up measures out of the total # of men enrolled Up to 6 months
Primary Adherence to the study Measured as the # of times that a man visits the portal over three months Up to 3 months
Secondary Community Healthy Activities Model Program for Seniors (CHAMPS) physical activity survey CHAMPS estimates total weekly energy expenditure (in kilocalories per week) from low to vigorous intensity physical activities for older adults. Baseline, 3 months, and 6 months
Secondary Harvard T.H. Chan School of Public Health Food Frequency Questionnaire for adults from 2007 This 132-item survey assesses dietary intake over the past month in categories from "never or less than once per month" to "6 or more times per day" and supports examining major food and nutrient categories of the U.S. diet. Baseline, 3 months, and 6 months
Secondary Self-Efficacy for Exercise A 6-item measure of Self-efficacy for Exercise will be used. Summed scores range from 6-30, and higher scores indicate higher self-efficacy. Baseline, 3 months, and 6 months
Secondary Physical Activity Stage Assessment This 5-question measure asks the person to select one description, from a choice of five, which describes his current activity behavior. Baseline, 3 months, and 6 months
Secondary Charlson Comorbidity Index The Charlson Comorbidity Index is a weighted index to predict mortality. Scores range from 0-37, with higher scores indicating more chronic medical conditions. Baseline, 3 months, and 6 months
Secondary Self-Efficacy for Diet Diet self-efficacy will be measured by having participants rate their confidence in performing each recommended task (e.g., two more servings of cooked tomatoes per week) using a Likert scale. Baseline, 3 months, and 6 months
Secondary Pittsburgh Sleep Quality Index This self-report questionnaire assesses sleep quality and disturbances over a 1-month time interval. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these seven components yields one global score. Baseline, 3 months, and 6 months
Secondary Memorial Anxiety Scale for Prostate Cancer (MAX-PC) MAX-PC is an 18 item scale to facilitate the identification and assessment of men with prostate cancer-related anxiety. This scale consists of three subscales that measure general prostate cancer anxiety, anxiety related to prostate specific antigen (PSA) levels in particular, and fear of recurrence. Baseline, 3 months, and 6 months
Secondary PROMIS 7-item Short Form - Fatigue PROMIS - Fatigue evaluates self-reported symptoms of fatigue, from mild subjective feelings of tiredness to an overwhelming sense of exhaustion over the past seven days. Baseline, 3 months, and 6 months
Secondary Behavioral Regulation in Exercise Questionnaire (BREQ2) BREQ2 measures the continuum of behavioral regulation in exercise psychology research. This questionnaire concerns the reasons why a person exercises regularly, works out, or engages in other such physical activities. It is structured so that it asks one question and provides responses that represent external regulation, introjected regulation, identified regulation, and intrinsic motivation. Baseline, 3 months, and 6 months
Secondary European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) EORTC QLQ-C30 is a 30-item questionnaire developed to assess the quality of life of cancer patients and has five functional scales (physical, role, cognitive, emotional, and social), three symptom scales (fatigue, pain, and nausea and vomiting), a global health status / QoL scale, and a number of single items assessing additional symptoms commonly reported by cancer patients (dyspnea, loss of appetite, insomnia, constipation and diarrhea) and perceived financial impact of the disease. Scores range from 0-100, with higher functional scale scores indicating a higher level of healthy functioning while a higher score for a symptom scale represents a higher level of symptomatology or problems. Baseline, 3 months, and 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04457232 - Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation Phase 1
Active, not recruiting NCT03661437 - Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy Early Phase 1
Completed NCT02337465 - KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer N/A
Completed NCT03013413 - Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy N/A
Recruiting NCT06037863 - Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial N/A
Active, not recruiting NCT03580499 - Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy N/A
Completed NCT03326440 - Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer N/A
Recruiting NCT04597359 - To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring Phase 2
Active, not recruiting NCT03263650 - Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC Phase 2
Active, not recruiting NCT04600336 - Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer Phase 2
Active, not recruiting NCT04299620 - Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy N/A
Completed NCT04976257 - Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion Early Phase 1
Completed NCT02957981 - The Genetic Education for Men Trial: Web-Based Education vs. Standard Care N/A
Withdrawn NCT03408561 - Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer N/A
Enrolling by invitation NCT06347809 - DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine
Enrolling by invitation NCT04254133 - Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study
Recruiting NCT05519878 - Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers N/A
Recruiting NCT02994758 - Development of Diagnostics and Treatment of Urological Cancers N/A
Completed NCT01497431 - Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants Phase 1
Active, not recruiting NCT00002540 - Screening for Prostate Cancer in Older Patients (PLCO Screening Trial) N/A